RFRI Jorhat Botany/Zoology JRF Vacancies
Title of the project with PI name: Assessment of insect pest problems of selected bamboo species in Assam and their management
PI: Sh. R. Raja Rishi
Junior Research Fellow (01)
Essential Qualification M.Sc. in Agriculture Entomology/M.Sc. Zoology with Entomology specialization/M.Sc. life Science.
Desirable qualification: Entomology background and knowledge in computer application
Emoluments: Rs. 12,000 + HRA as per rule
As Above Initially for one year which may be extended
The Posts are purely temporary. The Selected candidate may not claim for regular appointment at this Institute. The JRF, Field Assistants and Technical Assistants will have to assist the P.I. in doing the different field works. The walk-in-interview will be held on 8th July, 2010 (11.00 AM) in the Conference Hall, Rain Forest Research Institute, Jorhat, Assam.
The Candidates are requested to report the reception between 9.30 AM to 10.30 AM and submit their applications on the prescribed format. Original Certificates must be produced at the time of Interview. Candidate may apply more than one post. The decision of the Director, RFRI, Jorhat will be final and binding in all the matter pertaining to screening, interview and final selection.

No TA/DA will be admissible for appearing in the interview.
Adress:
Rain Forest Research Institute
P. Box No. 136
Jorhat, Assam
Source: http://www.icfre.org/UserFiles/File/advertisement_job/RFRI-Recruitment-JRF-&-FA-280610.pdf

--
support4bt@gmail.com
www.sitbiotech.blogspot.com
www.sitbiotech.yolasite.com
9739461028
9037652343

Computational Bioscience - compbio.ucdenver.edu/ - Earn your PhD in Computational Bioscience at UCDenver.

--
support4bt@gmail.com
www.sitbiotech.blogspot.com
www.sitbiotech.yolasite.com
9739461028
9037652343

csir questions

CSIR Questions !

Todays set of Questions are:
1) ras mutations are inherited to next generation through?
(a) environmental factors
(b) germ line mutations
(c) somatic mutation
(d) spontanous mutation
(e) none

2) Aberrent activation of------- pathway can contribute to the oncogenicity?
(a) anaerobic
(b) mitogenic
(c) carboxylic
(d) aerobic
(e) all

3) Which tumor suppressor gene is most frequently mutated in human cancers?
(a) RB12
(b) TP53
(c) RB84
(d) TP13
(e) ALL

4) Name one prominent factor in the response that arrests the cell
cycle which is activated by P53?
(a) TP53
(b) p21
(c) P-RB
(d) P-APC
(e) RB21

5) p21 is synthesized due to the cell stress by inactivating---------?
(a) DNA repair
(b) cyclins/CDKs complex
(c) protein complex
(d) DNA transcription
(e) all

6) START usually occurs during?
(a) mid-S
(b) mid-G1
(c) end of S
(d) mid-G2
(e) end-G1

7) The most common form of a dominant negative mutant is one that
forms -------- protein containing both mutant and wild type subunits
in p53?
(a) monomeric
(b) homomeric
(c) heteromeric
(d) polymeric
(e) none

8) Tumor T antigens have a variety of function in --------- type of cycle
(a) translation
(b) lytic
(c) lysogenic
(d) translocation
(e) reciprocation

9) The important of the connection between tumorigenesis and loss of
apoptosis is also shown by the properties of the ----- oncogenes?
(a) RB
(b) bcl2
(c) bcl8
(d) p53
(e) all

--
support4bt@gmail.com
www.sitbiotech.blogspot.com
www.sitbiotech.yolasite.com
9739461028
9037652343

An HIV vaccine is the theoretical vaccine which would be given to
persons without HIV in order to vaccinate them against getting HIV,
the virus which causes AIDS. No effective vaccine against HIV exists.
As there is no known cure for AIDS, the search for a vaccine has
become part of medical approaches against the disease.
It has been known for many years that HIV is an extremely difficult
virus to render harmless, and no cure presently exists. Research into
a vaccine is one of several strategies to reduce the worldwide harm
from AIDS, with other approaches based upon antiviral treatments such
as highly active antiretroviral therapy (HAART), and social approaches
such as safe sex.
There is evidence that a vaccine may be possible. Work with monoclonal
antibodies (MAb) has proven that the human body can defend itself
against HIV, and certain individuals remain asymptomatic for decades
after HIV infection. More recently in 2009, a number of potential
candidates for antibodies and early stage results from clinical trials
have been announced by various teams. However these are early results,
and have either not been developed to the point of human testing, or
not fully peer reviewed and replicated by other teams, at this time.

--
support4bt@gmail.com
www.sitbiotech.blogspot.com
www.sitbiotech.yolasite.com
9739461028
9037652343

important formulas

1. Molarity M = moles of solute * 1000 / Volume of solution
2. Molality m = moles of solute * 1000/ Mass of solvent in grams
3. Normality N = Gram equivalent weight of Solute * 1000 / Vol of solution
4. Normality = molarity * molecular mass/ equivalent weight
5. Mole fraction x = Moles of solute / (Moles of solute + Moles of Solvent)
6. Mole fraction of solute + Mole fraction of Solvent = 1
   
7. For acids:Normality  = Basicity * Molarity
8. For bases:Normality = Acidity * molarity
9. **Molarity = p * d * 10 / Molar mass (p = mass percentage, d = density of solution). This formula is generally used in laboratories to find the molarity of acids as no molarity is mentioned on the bottles only the purity and density is mention.
10. Normality = p * d * 10 / Equivalent weight
11. m = 1000 * M/ [(1000*d)-(M*gram molecular mass) of solute]
12. **Dilution formula: M1V1 = M2V2 and N1V1 = N2V2
13. **Resulting molarity of a solution is determined by the formula:  M = M1 .V1 + M2 .V2 / (V1 + V2)
14. **x2 = m M1 / (100 + m M1)
    x2 = mole fraction solute, m = molality, M1 = molar mass of solvent)
15. m = 1000 x2 / x1M1   ( x1= mole fraction of solvent)
16. **x2 =M .M1 / [(1000d - M.M2) + M.M1] (M = molarity, M1 = Molar mass of solvent, M2 = Molar mass of solute)
17. M = 100d .x2 / (x1 . M1 +  x2 .M2)

--
SITBT

Used Biotech Instruments - www.cgenetool.com - PCR/RT PCR, DNA seq(ABI3730,3100) Storm860/Typhoon9400. Centrifuge

--
SITBT

phd admission

Ph.D. Admission Secrets - www.HowIGotIntoStanford.com - True Story: How I Got Into the Stanford Psychology PhD Program

--
SITBT

gcp training

Web-based GCP Training - www.clinfosource.com - Enroll now! Convenient, affordable training in GCP clinical research

--
SITBT

coching

VPM CLASSES Biotechnology - www.vpmclasses.com - Best Biotech/Life Sciences COACHING for iit jam, jnu-ceeb,GATE, NET etc

--
SITBT

jobs

Cipla Job Vacancy - HTCareers.in/Pharma_Jobs - Jobs for Experienced Candidates Powered by Shine.com

--
SITBT